medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2019, Number 12

<< Back Next >>

Ginecol Obstet Mex 2019; 87 (12)

Difference in neutrophil/lymphocyte index between patients with polycystic ovarian syndrome and healthy women

Carranza-Lira S, Rodríguez-Acosta GC, Hernández-Ángeles LCE

Language: Spanish
References: 15
Page: 802-806
PDF size: 234.76 Kb.


ABSTRACT

Objective: To determine the difference in the neutrophil/lymphocyte index between PCOS patients and healthy women.
Materials and Methods: Descriptive, retrospective, cross-sectional, comparative study. Women with PCOS were studied in which glucose, lipids, testosterone, androstenedione and dehydroepiandrosterone sulfate were measured, also a blood count was performed, and the neutrophil/lymphocyte index was calculated. The results were compared with healthy controls studied for infertility. For statistical analysis, Mann- Whitney U and Spearman correlation analysis were used.
Results: 112 patients divided as follows were studied: group I with PCOS (n = 63) and group II healthy women (n = 49). The median age was for group I: 27 (14-39) and group II: 28 (16-41) years without statistically significant difference between them, also there were not between the groups in the concentrations of glucose, cholesterol and triglycerides. The neutrophil/lymphocyte index was significantly higher in the group with PCOS, 1.9 (0.9-7.4) vs 1.4 (0.8-3.9), p ‹ 0.000, respectively.
Conclusion: PCOS is associated with a chronic inflammatory process that may confer greater cardiovascular risk.


REFERENCES

  1. Azziz R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89(6):2745-9. doi: 10.1210/ jc.2003-032046

  2. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81 (1):19-25. doi: 10.1016/j.fertnstert. 2003.10.004

  3. Dahan MH, Reaven G. Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome. Endocrine. 2019 Mar 21. doi: 10.1007/s12020- 019-01899-9.

  4. Harris HR, et al. Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Int J Cancer. 2017; 140 (2): 285-91. doi: 10.1002/ijc.30441.

  5. Teede HJ, et al. International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110 (3): 364-79. doi: 10.1016/j. fertnstert.2018.05.004

  6. Kim JJ, et al. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2017; 45 (11): 1403-12. doi: 10.1111/apt.14058

  7. Pant S, et al. Inflammation and atherosclerosis--revisited. J Cardiovasc Pharmacol Ther 2014; 19 (2): 170-8. doi: 10.1177/1074248413504994

  8. Orio F Jr, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90 (1): 2-5. doi: 10.1210/jc.2004-0628

  9. Shi Y, et al. White blood cell differential counts in patients with polycystic ovary syndrome: a pilot study on Chinese women. Eur J Obstet Gynecol Reprod Biol 2013; 170 (1): 162-4. doi: 10.1016/j.ejogrb.2013.06.002

  10. Benson S, et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun. 2008; 22 (2): 177-84. doi: 10.1016/j. bbi.2007.07.003

  11. Yu JY, et al. Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults: An observational study. Medicine (Baltimore) 2019; 98 (9): e14740. doi: 10.1097/MD.0000000000014740

  12. Tsai JC, et al. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2007; 23 (2): 111-8. doi: 10.1002/dmrr.647

  13. Furuncuoğlu Y, et al. How obesity affects the neutrophil/ lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. 2016; 20: 1300-6. http://europepmc.org/abstract/ MED/27097950

  14. Aydin M, et al. Neutrophil/lymphocyte ratio in obese adolescents. North Clin Istanb. 2015; 2 (2): 87-91. DOI: 10.14744/nci.2015.25238

  15. Yilmaz MA, et al. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest 2016; 39: 45-53. https://doi.org/10.1007/s40618-015-0335-2




2020     |     www.medigraphic.com